VWR Corporation (NASDAQ:VWR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

According to Zacks, “VWR’s second-quarter earnings report was quite impressive, with both the top and the bottom line beating the Zacks Consensus Estimate. Geographically, the company recorded growth in Americas during the reported quarter driven by strong sales of equipment and instrumentation. Management is also looking forward to the long-term synergy benefits from the proposed merger with Avantor. The merger is expected to strengthen VWR’s business across the Americas and Europe. While we await the merger to close in the fourth quarter of 2017 we note that the stock price has already reached close to Avantor’s offer price and hence the short-term upside potential of VWR is limited now. On the flip side, a drop in EMEA-APAC sales was disappointing. Moreover, foreign currency was a major dampener. VWR’s poor margin scenario also raises concern.”

A number of other research analysts have also recently commented on VWR. BidaskClub cut VWR Corporation from a “sell” rating to a “strong sell” rating in a research report on Saturday, September 2nd. ValuEngine raised VWR Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, September 6th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $31.67.

Shares of VWR Corporation (NASDAQ VWR) opened at 33.24 on Thursday. VWR Corporation has a 12-month low of $24.42 and a 12-month high of $37.25. The stock has a 50 day moving average price of $33.10 and a 200 day moving average price of $31.92. The firm has a market cap of $4.38 billion, a P/E ratio of 30.78 and a beta of 1.18.

VWR Corporation (NASDAQ:VWR) last announced its quarterly earnings results on Monday, July 31st. The medical research company reported $0.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.45 by $0.04. VWR Corporation had a return on equity of 15.54% and a net margin of 3.12%. The business had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.16 billion. During the same quarter in the prior year, the company posted $0.42 earnings per share. VWR Corporation’s revenue was up 2.2% compared to the same quarter last year. On average, equities analysts expect that VWR Corporation will post $1.86 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Zacks Investment Research Downgrades VWR Corporation (VWR) to Hold” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.thecerbatgem.com/2017/10/07/zacks-investment-research-downgrades-vwr-corporation-vwr-to-hold.html.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Amalgamated Bank increased its stake in VWR Corporation by 1.7% in the 1st quarter. Amalgamated Bank now owns 11,202 shares of the medical research company’s stock worth $316,000 after acquiring an additional 183 shares during the last quarter. Neuberger Berman Group LLC increased its stake in VWR Corporation by 3.0% in the 2nd quarter. Neuberger Berman Group LLC now owns 7,981 shares of the medical research company’s stock worth $263,000 after acquiring an additional 229 shares during the last quarter. Principal Financial Group Inc. increased its stake in VWR Corporation by 2.7% in the 1st quarter. Principal Financial Group Inc. now owns 17,339 shares of the medical research company’s stock worth $489,000 after acquiring an additional 450 shares during the last quarter. Public Employees Retirement System of Ohio increased its stake in VWR Corporation by 3.4% in the 1st quarter. Public Employees Retirement System of Ohio now owns 31,762 shares of the medical research company’s stock worth $896,000 after acquiring an additional 1,031 shares during the last quarter. Finally, Capital Insight Partners LLC increased its stake in VWR Corporation by 4.4% in the 2nd quarter. Capital Insight Partners LLC now owns 46,748 shares of the medical research company’s stock worth $1,543,000 after acquiring an additional 1,962 shares during the last quarter.

About VWR Corporation

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

Receive News & Stock Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related stocks with our FREE daily email newsletter.